subject: UMLS:C3272416

subject_name: PSMA-targeted Docetaxel Nanoparticles BIND-014

object_name: non-small cell squamous lung carcinoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: ovarian cancer

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:44424639

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:44424639

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: primary peritoneal carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Primary Peritoneal Cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: fallopian tube carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: fallopian tube cancer


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: UMLS:C2348671

subject_name: Fentanyl Sublingual Spray

object_name: Burning Pain

tested_intervention: yes


subject: UMLS:C5709326

object_name: Duchenne muscular dystrophy


subject: DRUGBANK:DB17004


subject: UniProtKB:P59665

subject_name: DEF1_HUMAN Neutrophil defensin 1 (sprot)

object_name: type 2 diabetes mellitus


subject: CHEBI:6121

subject_name: Ketamine

object_name: Hemodynamic instability


subject: CHEBI:6121

object_name: Postoperative delirium


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Cognitive impairment


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802

object_name: Emergence Delirium


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:76128

object_name: Dysmenorrhea


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:6456

subject_name: Lidocaine

object_name: pelvic pain on the left


subject: CHEBI:6456

object_name: pelvic pain occurs with urination


subject: CHEBI:6456

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:6456

object_name: pelvic pain decreasing in severity


subject: CHEBI:6456

object_name: Pelvic pain female


subject: CHEBI:6456

object_name: pelvic pain increasing in severity


subject: CHEBI:6456

object_name: male pelvic pain


subject: CHEBI:6456

object_name: pelvic pain to the rear


subject: CHEBI:6456

object_name: pelvic pain on the right


subject: CHEBI:6456

object_name: pelvic pain decreasing in frequency


subject: CHEBI:6456

object_name: Pelvic pain


subject: CHEBI:6456

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:6456

object_name: pelvic pain causes awakening at night


subject: CHEBI:6456

object_name: pelvic pain increasing in frequency


subject: CHEBI:6456

object_name: pelvic pain occurs with intercourse


subject: CHEBI:6456

object_name: pelvic pain in front


subject: CHEBI:49603

subject_name: Lapatinib

object_name: renal cell carcinoma


subject: UMLS:C0717761

subject_name: ethinyl estradiol / levonorgestrel

object_name: Uses contraception (finding)


subject: UMLS:C0717761

object_name: bariatric surgery candidate


subject: CHEBI:26333

subject_name: prostaglandin

object_name: glaucoma


subject: CHEBI:26333

object_name: Glaucoma, CTCAE


subject: UNII:74T7185BMM

subject_name: Inebilizumab

object_name: neuromyelitis optica


subject: UMLS:C2981806


subject: DRUGBANK:DB12814

subject_name: Cepeginterferon alfa-2B

object_name: hepatitis C


subject: DRUGBANK:DB12814

object_name: hepatitis A


subject: DRUGBANK:DB12814

object_name: hepatitis


subject: UMLS:C4519916

subject_name: Algeron


subject: UMLS:C4519916


subject: UMLS:C4519916


subject: CHEBI:91385

object_name: neoplasm


subject: MESH:C532366


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: rheumatoid arthritis


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:47458

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:47458

object_name: metastatic melanoma


subject: CHEBI:47458

object_name: stage IIC melanoma


subject: CHEBI:47458

object_name: Stage IIB Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:47458

object_name: stage IIB melanoma


subject: CHEBI:47458

object_name: stage IIA melanoma


subject: CHEBI:47458

object_name: Melanoma recurrent


subject: UMLS:C4331906

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C4331906

object_name: prostate cancer


subject: UMLS:C4331906

object_name: prostate neoplasm


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:74540

subject_name: Leu-Ile

object_name: chronic hepatitis C virus infection


subject: CHEBI:30145

subject_name: lithium atom


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:6456

object_name: Congenital postural scoliosis


subject: CHEBI:6456

object_name: scoliosis


subject: CHEBI:6456

object_name: Scoliosis, CTCAE


subject: CHEBI:63607

subject_name: Linezolid

object_name: primary syphilis


subject: CHEBI:63607

object_name: chancre


subject: CHEBI:63607

object_name: secondary syphilis


subject: CHEBI:63607

object_name: latent early syphilis


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: lung cancer


subject: PUBCHEM.COMPOUND:6435378

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:6435378

object_name: lung carcinoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage I Lung Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IA2 Lung Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IA3 Lung Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IB Lung Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IA1 Lung Cancer AJCC v8


subject: CHEBI:231614

object_name: Lung adenocarcinoma recurrent


subject: CHEBI:231614

object_name: Large cell lung cancer recurrent


subject: CHEBI:231614

object_name: Well-differentiated neuroendocrine tumor grade 2 of lung


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5204531

subject_name: A2AR/A2BR Antagonist AB928

object_name: colorectal cancer


subject: UMLS:C5204531

object_name: colorectal carcinoma


subject: UMLS:C5204531

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323


subject: UNII:R30772KCU0

subject_name: Isatuximab


subject: UNII:R30772KCU0


subject: UNII:R30772KCU0


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: CHEMBL.COMPOUND:CHEMBL2109477

subject_name: SELICRELUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109477


subject: CHEMBL.COMPOUND:CHEMBL2109477


subject: UMLS:C1869412


subject: UMLS:C1869412


subject: UMLS:C1869412


subject: CHEBI:32058

subject_name: Proglumide

object_name: Metastatic malignant neoplasm to pancreas


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: lip and oral cavity carcinoma


subject: PR:000014196

object_name: oral cavity cancer


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: CHEBI:64816

object_name: Early Stage Breast Carcinoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:40574

subject_name: acetyl group


subject: CHEBI:33337

subject_name: Actinium


subject: CHEBI:157787

subject_name: Ala-Cys


subject: PR:000004336

subject_name: acid ceramidase


subject: CHEBI:157903

subject_name: Tyr-Cys


subject: CHEBI:33353

subject_name: technetium atom


subject: UMLS:C0040642

subject_name: Transcobalamin


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: carcinoma of esophagus


subject: UNII:GKF8S4C432

object_name: esophageal cancer


subject: UNII:GKF8S4C432

object_name: Childhood Esophageal Carcinoma


subject: UNII:GKF8S4C432

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: PUBCHEM.COMPOUND:9831414

object_name: Fatty Liver


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UMLS:C2984015

object_name: malignant pleural mesothelioma


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: glucose intolerance


subject: CHEBI:27300

object_name: Glucose Intolerance, CTCAE


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3641660

subject_name: PI3K Alpha/Beta Inhibitor BAY1082439

object_name: neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: cholangiocarcinoma


subject: CHEBI:41879

object_name: liver neoplasm


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Pregnant


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UMLS:C3832695

subject_name: Budesonide Nasal (Brand Name)

object_name: chronic rhinosinusitis


subject: UNII:UI1U1MYH09

subject_name: Darapladib

object_name: arteriosclerosis disorder


subject: UNII:UI1U1MYH09

object_name: atherosclerosis


subject: UMLS:C2348075

subject_name: darapladib


subject: UMLS:C2348075


subject: UMLS:C2830036

object_name: Childhood Breast Carcinoma


subject: UMLS:C2830036

object_name: breast carcinoma


subject: UMLS:C2830036

object_name: breast cancer


subject: UMLS:C2830036

object_name: Embolism, Tumor


subject: UMLS:C2830036

object_name: Neoplasm Metastasis


subject: UMLS:C2830036

object_name: Metastasis


subject: UMLS:C2830036

object_name: Metastatic Lesion


subject: CHEBI:6909

subject_name: Metronidazole

object_name: Postoperative infection


subject: CHEBI:53076

object_name: Advanced Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:34650

subject_name: COLISTIMETHATE

object_name: childhood malignant neoplasm


subject: CHEBI:34650

object_name: gram-negative bacterial infections


subject: CHEBI:34650

object_name: Colistin adverse reaction


subject: CHEBI:34650

object_name: Ductal Carcinoma In Situ with Microinvasion


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:37943


subject: CHEBI:37943


subject: CHEBI:37943


subject: GTOPDB:13790

subject_name: benmelstobart

object_name: non-small cell lung carcinoma


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: UNII:U65F5M6BD5

subject_name: REZIVERTINIB


subject: MESH:C000728929

subject_name: rezivertinib


subject: CHEBI:177298

object_name: Carcinoma breast stage IV


subject: CHEBI:177298

object_name: Advanced breast cancer


subject: CHEBI:177298

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:177298

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:177298

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:177298

object_name: fallopian tube carcinoma


subject: CHEBI:177298

object_name: fallopian tube cancer


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: peritoneum cancer


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: Menopause present (finding)


subject: DRUGBANK:DB14101

object_name: Menopause


subject: DRUGBANK:DB14101

object_name: osteoporosis


subject: DRUGBANK:DB14101

object_name: Encounter due to family history of osteoporosis


subject: DRUGBANK:DB14101

object_name: Osteoporosis, CTCAE 5.0


subject: DRUGBANK:DB14101

object_name: Osteoporosis, CTCAE 3.0


subject: DRUGBANK:DB14101

object_name: Osteopenia


subject: PUBCHEM.COMPOUND:118282339

object_name: psoriasis


subject: UMLS:C4733602

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C4733602

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C4733602

object_name: metastatic melanoma


subject: UMLS:C4733602

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C2934702


subject: CHEBI:15891

subject_name: Taurine

object_name: Sarcopenic obesity


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate


subject: UMLS:C3661275

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:6904

subject_name: Metoprolol

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:6904

object_name: Childhood Solid Neoplasm


subject: CHEBI:6904

object_name: Adult Solid Neoplasm


subject: CHEBI:6904

object_name: Solid Neoplasm


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: UNII:B72HH48FLU


subject: UNII:B72HH48FLU


subject: UNII:B72HH48FLU


subject: CHEBI:4875

subject_name: Etanercept


subject: CHEBI:4875


subject: CHEBI:4875


subject: CHEBI:4875


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: PUBCHEM.COMPOUND:96919

subject_name: Castor oil

object_name: post term pregnancy


subject: CHEBI:140618


subject: CHEBI:4910

subject_name: Etomidate

object_name: stroke disorder


subject: CHEBI:4910

object_name: cerebrovascular disorder


subject: CHEBI:4910

object_name: Stroke (heart beat)


subject: CHEBI:4910

object_name: Stroke, CTCAE


subject: CHEBI:4910

object_name: brain ischemia


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:37537

subject_name: Phorbol 12-myristate 13-acetate diester


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:53394

subject_name: phosphotungstic acid macromolecule


subject: CHEBI:53394


subject: CHEBI:53394


subject: CHEBI:53394


subject: CHEBI:53394


subject: CHEBI:61432

subject_name: phosphotungstic acid polymer


subject: CHEBI:61432


subject: CHEBI:61432


subject: CHEBI:61432


subject: CHEBI:61432


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: pituitary dwarfism


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:4877

subject_name: Ethambutol

object_name: anterior uveitis


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: malignant mesothelioma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: choanal atresia


subject: UNII:9AG41L3AOQ

object_name: primary cutaneous amyloidosis


subject: UNII:9AG41L3AOQ

object_name: posterior cortical atrophy


subject: UNII:9AG41L3AOQ

object_name: amyloidosis, primary localized cutaneous, 1


subject: UNII:9AG41L3AOQ

object_name: PSA Progression


subject: CHEBI:79033

subject_name: florbetaben F18

object_name: subjective cognitive decline


subject: CHEBI:135697

subject_name: Sarpogrelate

object_name: coronary artery disorder


subject: CHEBI:135697

object_name: coronary atherosclerosis


subject: UMLS:C3490678

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C3490678

object_name: Recurrent Glioblastoma


subject: CHEBI:30430

subject_name: indium atom

object_name: Parkinson disease


subject: CHEBI:74063

subject_name: Ile-Asn


subject: CHEBI:30429

subject_name: Indium


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: liver carcinoma


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UMLS:C5565156

object_name: atopic eczema


subject: CHEBI:7936

subject_name: Paroxetine

object_name: rheumatoid arthritis


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Locally Advanced Rectal Carcinoma


subject: CHEBI:31348

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIC Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIA Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIB Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: rectum adenocarcinoma


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:7459

subject_name: Naloxone

object_name: cancer


subject: CHEBI:7459

object_name: neoplasm


subject: UMLS:C1831604


subject: MESH:C504257

subject_name: 177Lu-octreotide, DOTA(0)-Tyr(3)-

object_name: paraganglioma


subject: MESH:C504257

object_name: neuroendocrine neoplasm


subject: MESH:C504257

object_name: adrenal gland pheochromocytoma


subject: MESH:C504257

object_name: pheochromocytoma


subject: MESH:C504257

object_name: Unknown Primary Tumors


subject: MESH:C504257

object_name: lung neuroendocrine neoplasm


subject: MESH:C504257

object_name: Neuroendocrine breast tumour


subject: MESH:C504257

object_name: cutaneous neuroendocrine carcinoma


subject: MESH:C504257

object_name: ovarian neuroendocrine neoplasm


subject: MESH:C504257

object_name: Metastatic neuroendocrine carcinoma


subject: MESH:C504257

object_name: thymic neuroendocrine tumor


subject: UMLS:C2981799

subject_name: edotreotide lutetium LU-177


subject: UMLS:C2981799


subject: UMLS:C2981799


subject: UMLS:C2981799


subject: UMLS:C2981799


subject: UMLS:C2981799


subject: UMLS:C2981799


subject: UMLS:C2981799


subject: UMLS:C2981799


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Cough


subject: CHEBI:70746

object_name: Cough, CTCAE


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:5296

subject_name: Gemfibrozil


subject: CHEBI:5296


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Inflammatory carcinoma of breast recurrent


subject: UNII:52CMI0WC3Y

object_name: Inflammatory carcinoma of breast stage IV


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid


subject: CHEBI:231005


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: aortic stenosis symptomatic


subject: UMLS:C4764024

subject_name: Anti-FolRa ADC STRO-002

object_name: cancer


subject: CHEBI:134990

subject_name: Agomelatine

object_name: endogenous depression


subject: UNII:MNZ4OP95CF

subject_name: Senaparib

object_name: ovarian cancer


subject: UNII:MNZ4OP95CF

object_name: ovarian neoplasm


subject: UNII:MNZ4OP95CF

object_name: fallopian tube carcinoma


subject: UNII:MNZ4OP95CF

object_name: fallopian tube cancer


subject: UNII:MNZ4OP95CF

object_name: peritoneum cancer


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Stomach cancer


subject: UNII:GKF8S4C432

object_name: gastric cancer


subject: CHEBI:35627

subject_name: beta-lactam

object_name: Soft Tissue Infection


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499

object_name: ovarian carcinoma


subject: CHEBI:8499

object_name: OVARIAN CANCER METASTATIC RECURRENT


subject: CHEBI:35530

subject_name: beta-adrenergic antagonist


subject: CHEBI:35530


subject: CHEBI:35530


subject: CHEBI:35530


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: CHEBI:50629

subject_name: cyclooxygenase 2 inhibitor


subject: CHEBI:50629


subject: CHEBI:50629


subject: CHEBI:50629


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: osteoarthritis, hip


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:135117

subject_name: ftivazide

object_name: diabetes mellitus


subject: CHEBI:6030

subject_name: Isoniazid


subject: HMDB:HMDB0015332

subject_name: Rifapentine


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Control of hip fracture risk


subject: PUBCHEM.COMPOUND:74030550

object_name: hip fracture


subject: UMLS:C2830052

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C2830052

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2830052

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C2830052

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C2830052

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C2830052

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C2830052

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C2830052

object_name: MALT lymphoma


subject: UMLS:C2830052

object_name: splenic marginal zone lymphoma


subject: UMLS:C2830052

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:135515

subject_name: Bendamustine


subject: CHEBI:135515


subject: CHEBI:135515


subject: CHEBI:135515


subject: CHEBI:135515


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: no feeling or sensation of skin


subject: UMLS:C0360094

object_name: Sensory Loss


subject: UNII:09936A4QSN

subject_name: Simpinicline

object_name: dry eye syndrome


subject: CHEBI:17499

subject_name: hydrogen donor

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:17499

object_name: acute myeloid leukemia


subject: CHEBI:17499

object_name: Myelodysplasia


subject: CHEBI:17499

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:17499

object_name: childhood myelodysplastic syndrome


subject: CHEBI:17499

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:17891

subject_name: donor


subject: CHEBI:17891


subject: CHEBI:17891


subject: CHEBI:17891


subject: CHEBI:17891


subject: CHEBI:17891


subject: UMLS:C3896672

subject_name: Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C3896672

object_name: Recurrent ovarian cancer


subject: UMLS:C3896672

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C3896672

object_name: Recurrent Primary Peritoneal Carcinosarcoma


subject: UMLS:C3896672

object_name: Primary peritoneal carcinosarcoma


subject: UMLS:C3896672

object_name: Recurrent Ovarian Carcinosarcoma


subject: UMLS:C3896672

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: UMLS:C3896672

object_name: Recurrent Fallopian Tube Clear Cell Adenocarcinoma


subject: UMLS:C3896672

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C3896672

object_name: fallopian tube carcinosarcoma


subject: UMLS:C3896672

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UMLS:C3896672

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: UMLS:C3896672

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: UMLS:C3896672

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: UMLS:C3896672

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C3896672

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: mild neurocognitive disorder


subject: CHEBI:17154

object_name: mild cognitive impairment


subject: CHEBI:17154

object_name: Alzheimer disease


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: pancreatic neoplasm


subject: CHEBI:3515

object_name: exocrine pancreatic carcinoma


subject: CHEBI:3515

object_name: malignant pancreatic neoplasm


subject: CHEBI:66910

subject_name: Axitinib

object_name: papillary renal cell carcinoma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Her2-receptor negative breast cancer


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Neurogenic bladder


subject: CHEBI:91697

object_name: ovarian cancer


subject: CHEBI:91697

object_name: ovarian neoplasm


subject: CHEBI:91697

object_name: ovarian carcinoma


subject: CHEBI:65310

subject_name: Triciribine


subject: CHEBI:65310


subject: CHEBI:65310


subject: MESH:C000624485

subject_name: cefepime-zidebactam

object_name: Complicated urinary tract infection


subject: MESH:C000624485

object_name: acute pyelonephritis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Angiomyolipoma


subject: UMLS:C4086017

subject_name: BTK Inhibitor

object_name: Hepatic impairment


subject: CHEBI:60802

subject_name: ropivacaine

object_name: cerebral palsy


subject: CHEBI:27732

subject_name: Caffeine

object_name: perinatal asphyxia


subject: CHEBI:27732

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:27732

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:27732

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:27732

object_name: acute kidney failure


subject: CHEBI:27732

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:47657

subject_name: Roflumilast

object_name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ALLIED CONDITIONS


subject: PUBCHEM.COMPOUND:44151255

subject_name: Dirucotide

object_name: relapsing-remitting multiple sclerosis


subject: UNII:26188K0CWH


subject: UMLS:C4282231


subject: PUBCHEM.COMPOUND:46874763

object_name: antibiotic side-effect


subject: PUBCHEM.COMPOUND:46874763

object_name: Bacterial ear infection


subject: PUBCHEM.COMPOUND:46874763

object_name: Surgical Wound Infection


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: CHEBI:15365

subject_name: Aspirin

object_name: endometrial cancer


subject: CHEBI:15365

object_name: uterine corpus cancer


subject: CHEBI:15365

object_name: endometrial carcinoma


subject: CHEBI:15365

object_name: cervical cancer


subject: CHEBI:15365

object_name: cervical carcinoma


subject: CHEBI:15365

object_name: uterine cancer


subject: CHEBI:15365

object_name: tumor of uterus


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:6375

subject_name: Lansoprazole


subject: CHEBI:6375


subject: CHEBI:6375


subject: CHEBI:6375


subject: CHEBI:6375


subject: CHEBI:6375


subject: CHEBI:6375


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: MESH:C519882

subject_name: chloroguanil, dapsone drug combination

object_name: Plasmodium falciparum malaria


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Upper limb spasticity


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Postoperative Hemorrhage, CTCAE


subject: CHEBI:28918

object_name: Postoperative Hemorrhage


subject: CHEBI:194548

subject_name: Racepinephrine


subject: CHEBI:194548


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:41948

subject_name: Eflornithine

object_name: precancerous condition


subject: CHEBI:6801

subject_name: Metformin

object_name: type 1 diabetes mellitus 1


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:231679

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEBI:231679

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Adenocarcinoma of colon metastatic


subject: CHEBI:231679

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVC Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:231679

object_name: Metastatic rectal adenocarcinoma


subject: CHEBI:231679

object_name: Advanced Colon Adenocarcinoma


subject: CHEBI:231679

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVC Colon Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:231614

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Adenocarcinoma of colon metastatic


subject: CHEBI:231614

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVC Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Metastatic rectal adenocarcinoma


subject: CHEBI:231614

object_name: Advanced Colon Adenocarcinoma


subject: CHEBI:231614

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVC Colon Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C2346820

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Adenocarcinoma of colon metastatic


subject: UMLS:C2346820

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVC Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Metastatic rectal adenocarcinoma


subject: UMLS:C2346820

object_name: Advanced Colon Adenocarcinoma


subject: UMLS:C2346820

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVC Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:68646

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Adenocarcinoma of colon metastatic


subject: CHEBI:68646

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IVC Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Metastatic rectal adenocarcinoma


subject: CHEBI:68646

object_name: Advanced Colon Adenocarcinoma


subject: CHEBI:68646

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IVC Colon Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:68647

subject_name: Regorafenib

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:68647

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:68647

object_name: Adenocarcinoma of colon metastatic


subject: CHEBI:68647

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IVC Rectal Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:68647

object_name: Metastatic rectal adenocarcinoma


subject: CHEBI:68647

object_name: Advanced Colon Adenocarcinoma


subject: CHEBI:68647

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IVC Colon Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:68647

object_name: Stage IIIA Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Hyponatremia


subject: PUBCHEM.COMPOUND:73151030

object_name: Hyponatremia, CTCAE


subject: PUBCHEM.COMPOUND:73151030

object_name: liver failure


subject: PUBCHEM.COMPOUND:73151030

object_name: kidney failure


subject: PUBCHEM.COMPOUND:73151030

object_name: inappropriate ADH syndrome


subject: CHEBI:188074

object_name: inflammatory bowel disease


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: neuromyelitis optica


subject: UMLS:C2934225


subject: MESH:C520497

subject_name: MoviPrep

object_name: colorectal disorders


subject: PUBCHEM.COMPOUND:73151030

object_name: Childhood Kidney Disorder


subject: CHEBI:63631

subject_name: Topiramate

object_name: Weight loss


subject: CHEBI:63631

object_name: Weight Loss, CTCAE


subject: CHEBI:63631

object_name: Post-Operative Pain


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: bacterial infectious disease


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: UMLS:C5417784

object_name: triple-negative breast carcinoma


subject: UMLS:C5417784

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5417784

object_name: cervical cancer


subject: UMLS:C5417784

object_name: cervical carcinoma


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: acute chest syndrome


subject: UNII:I031V2H011

object_name: sickle cell disease


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PUBCHEM.COMPOUND:56776542

subject_name: Andecaliximab

object_name: cystic fibrosis


subject: UNII:571045EIM4

subject_name: andecaliximab


subject: UMLS:C3827124


subject: CHEBI:47898

subject_name: Epirubicin

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:MJ95C3OH47

subject_name: olive leaf extract

object_name: anxiety disorder


subject: CHEBI:25667

subject_name: oleoyl group


subject: CHEBI:63115

subject_name: Fingolimod

object_name: intracerebral hemorrhage


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:53477758

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:53477758

object_name: hypotension


subject: PUBCHEM.COMPOUND:53477758

object_name: Hypotension, CTCAE


subject: PUBCHEM.COMPOUND:53477758

object_name: Blood Loss


subject: PUBCHEM.COMPOUND:53477758

object_name: Hemorrhage


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Overweight


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: MESH:D003287

subject_name: Contrast Media

object_name: chronic kidney disease


subject: MESH:D003287

object_name: Chronic uremia


subject: CHEBI:31705

subject_name: Iodixanol


subject: CHEBI:60799

subject_name: Esketamine

object_name: irritable bowel syndrome


subject: CHEBI:91985

subject_name: nadolol

object_name: capillary infantile hemangioma


subject: CHEBI:91985

object_name: Spider nevus


subject: PUBCHEM.COMPOUND:14794883

subject_name: Folerogenin


subject: PUBCHEM.COMPOUND:14794883


subject: UMLS:C4733687

subject_name: Adenoviral Cancer Vaccine PF-06936308

object_name: triple-negative breast carcinoma


subject: UMLS:C4733687

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4733687

object_name: non-small cell lung carcinoma


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Increased reactive oxygen species production


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: end stage renal failure


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: UMLS:C0795657

subject_name: Aralast

object_name: type 1 diabetes mellitus


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: CHEBI:63608

subject_name: Maraviroc

object_name: stroke disorder


subject: CHEBI:63608

object_name: cerebrovascular disorder


subject: CHEBI:63608

object_name: Stroke (heart beat)


subject: CHEBI:63608

object_name: Stroke, CTCAE


subject: CHEBI:15379

subject_name: Oxygen

object_name: pulmonary embolism


subject: CHEBI:15379

object_name: venous thromboembolism


subject: CHEBI:15379

object_name: thrombophilia due to thrombin defect


subject: MESH:C013007

subject_name: gonyautoxins

object_name: Tension-type headache


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Actively extending plaque psoriasis


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: Spastic Dysphonia


subject: CHEBI:30830

object_name: Dysphonia


subject: CHEBI:30830

object_name: Voice tremor


subject: CHEBI:51147

subject_name: pramipexole hydrochloride

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:51147

object_name: amyotrophic lateral sclerosis


subject: UMLS:C1579413

subject_name: Pramipexole dihydrochloride monohydrate


subject: UMLS:C1579413


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide

object_name: kidney failure


subject: UMLS:C1098514


subject: CHEBI:6121

subject_name: Ketamine

object_name: Fracture, CTCAE


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:135582802

object_name: Bacteremia, CTCAE


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: CHEBI:140407


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: sickle cell disease


subject: UMLS:C2608320

object_name: fetal growth restriction


subject: UMLS:C4743011

object_name: lupus nephritis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Decreased circulating vitamin E concentration


subject: CHEBI:89324

object_name: vitamin A deficiency


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803

object_name: vitamin D deficiency


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:71255

subject_name: Asenapine

object_name: bipolar depression


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: CHEBI:60799

subject_name: Esketamine

object_name: chronic rhinosinusitis


subject: CHEBI:32599


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: rheumatoid arthritis


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UMLS:C5417823


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: central retinal artery occlusion


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: GTOPDB:5962

subject_name: dovitinib

object_name: plasma cell myeloma


subject: CHEBI:9169

subject_name: Sisomicin

object_name: pyoderma


subject: UMLS:C3714803

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Pneumonia caused by SARS-CoV-2


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: myotonic dystrophy type 1


subject: PUBCHEM.COMPOUND:73151030

object_name: Double Minutes


subject: PUBCHEM.COMPOUND:73151030

object_name: dermatomyositis


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: HIV-1 infection


subject: GTOPDB:4977

object_name: Neck Carcinoma


subject: GTOPDB:4977

object_name: head and neck neoplasm


subject: GTOPDB:4977

object_name: head and neck cancer


subject: UMLS:C0123759


subject: UMLS:C0123759


subject: UMLS:C0123759


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: PUBCHEM.COMPOUND:73151030

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:73151030

object_name: inflammatory bowel disease 1


subject: CHEBI:63631

subject_name: Topiramate

object_name: Binge eating behavior


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: chronic obstructive pulmonary disease


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: chronic kidney disease


subject: CHEBI:37941

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:31401

subject_name: Cilostazol


subject: CHEBI:31401


subject: CHEBI:31401

object_name: Angina pectoris


subject: UMLS:C3274843

subject_name: pbi-shRNA STMN1 Lipoplex

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C3274843

object_name: Embolism, Tumor


subject: UMLS:C3274843

object_name: Neoplasm Metastasis


subject: UMLS:C3274843

object_name: Advanced cancer


subject: UMLS:C3274843

object_name: Solid Neoplasm


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel

object_name: primary central nervous system lymphoma


subject: CHEBI:136037

subject_name: Corticorelin

object_name: gastrointestinal; hypersensitivity


subject: CHEBI:60802

subject_name: ropivacaine

object_name: opioid use


subject: UNII:FBK9G669EY

subject_name: CHO CELL

object_name: Coronavinae infectious disease


subject: CHEBI:136051

subject_name: Lusutrombopag

object_name: thrombocytopenia


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Renal Colic, CTCAE


subject: CHEBI:6129

object_name: renal colic


subject: CHEBI:6129

object_name: Emergencies


subject: CHEBI:6129

object_name: Flank Pain, CTCAE


subject: CHEBI:6129

object_name: Flank pain


subject: CHEBI:567361

subject_name: Cladribine

object_name: myeloid neoplasm


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C0376562

subject_name: Recombinant Granulocyte Colony Stimulating Factor


subject: UMLS:C0376562

object_name: Refractory acute myeloid leukemia


subject: UMLS:C0376562


subject: CHEBI:45783

subject_name: Imatinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:45783

object_name: breast carcinoma


subject: CHEBI:45783

object_name: breast cancer


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: colon carcinoma


subject: UNII:28X28X9OKV

object_name: colon cancer


subject: UNII:28X28X9OKV

object_name: Malignant tumor of digestive organ


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:135686

subject_name: Alvimopan

object_name: bladder tumor


subject: CHEBI:135686

object_name: urinary bladder carcinoma


subject: CHEBI:135686

object_name: urinary bladder cancer


subject: CHEBI:135686

object_name: childhood bladder carcinoma


subject: UNII:FBK9G669EY

object_name: chronic kidney disease


subject: UNII:FBK9G669EY

object_name: Chronic uremia


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: metastatic melanoma


subject: UNII:52CMI0WC3Y

object_name: Refractory Melanoma


subject: UNII:52CMI0WC3Y

object_name: Primary intracranial melanoma


subject: UNII:52CMI0WC3Y

object_name: metastatic malignant neoplasm in the brain


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: BRAF V600 Wild Type


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Richter syndrome


subject: UMLS:C1541395


subject: CHEBI:44915

subject_name: Propofol

object_name: Propofol overdose of undetermined intent


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Genital warts


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: adult lymphoma


subject: UNII:LDJ89SS0YG

object_name: lymphoma


subject: UNII:LDJ89SS0YG

object_name: pediatric lymphoma


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: sickle cell disease


subject: CHEBI:25681

object_name: Vaso-Occlusive Crisis


subject: CHEBI:25681

object_name: Sickle cell anemia in children


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:87631


subject: CHEBI:87631


subject: UMLS:C0007220

subject_name: Cardiovascular Agents


subject: UMLS:C0007220


subject: UMLS:C0007220


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:35176

subject_name: Zinc sulfate


subject: CHEBI:35176


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Pulmonary Complication


subject: CHEBI:5494

subject_name: ritropirronium bromide


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEMBL.COMPOUND:CHEMBL2108570

subject_name: ABOBOTULINUMTOXINA

object_name: Raynaud disease


subject: UMLS:C2729275

subject_name: INJECTION, ABOBOTULINUMTOXINA, 5 UNITS


subject: UMLS:C5557492

object_name: Childhood Breast Carcinoma


subject: UMLS:C5557492

object_name: breast carcinoma


subject: UMLS:C5557492

object_name: breast cancer


subject: UMLS:C5557492

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5557492

object_name: triple-negative breast carcinoma


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:123315041

subject_name: VIBEGRON

object_name: irritable bowel syndrome


subject: UMLS:C1831942

object_name: liver carcinoma


subject: UMLS:C5557949

subject_name: Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F capsular polysaccharide conjugated antigens only vaccine product

object_name: streptococcal pneumonia


subject: CHEMBL.COMPOUND:CHEMBL1201458

subject_name: ETHIODIZED OIL

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C0538777

subject_name: ancestim


subject: UMLS:C0538777

object_name: sickle cell-hemoglobin c disease syndrome


subject: CHEMBL.COMPOUND:CHEMBL5095458

subject_name: REZPEGALDESLEUKIN

object_name: type 1 diabetes mellitus 1


subject: CHEMBL.COMPOUND:CHEMBL5095458

object_name: type 1 diabetes mellitus


subject: UMLS:C5707940

subject_name: Rezpegaldesleukin


subject: UMLS:C5707940


subject: CHEBI:5383

subject_name: Glimepiride

object_name: Diabetes


subject: CHEBI:31687

subject_name: Idebenone

object_name: primary progressive multiple sclerosis


subject: CHEBI:31687

object_name: multiple sclerosis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Large cell lung cancer recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Large cell lung cancer stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Lung adenocarcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Lung squamous cell carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Adenocarcinoma of lung, stage IV


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:9123

subject_name: Sertraline

object_name: Gambling


subject: UNII:94X46KW4AE

subject_name: Amenamevir

object_name: genital herpes


subject: UNII:94X46KW4AE

object_name: Genital herpes male


subject: UNII:94X46KW4AE

object_name: genital herpes in women


subject: UNII:94X46KW4AE

object_name: herpes zoster


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: acute myeloid leukemia


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Stage III Colon Cancer AJCC v8


subject: GTOPDB:12989

object_name: Stage IIB Colon Cancer AJCC v8


subject: GTOPDB:12989

object_name: Stage IIC Colon Cancer AJCC v8


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: brain glioblastoma


subject: UMLS:C3896806


subject: UNII:MZ37792Y8J

subject_name: Oprozomib

object_name: plasma cell myeloma


subject: UMLS:C2984209


subject: UNII:PQX0D8J21J

object_name: cancer


subject: UMLS:C0879636


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: sickle cell disease


subject: CHEBI:16480

object_name: acute chest syndrome


subject: CHEBI:600103

subject_name: daptomycin

object_name: staphylococcus aureus infection


subject: GTOPDB:12962

subject_name: sotatercept


subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: UMLS:C2699571


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: non-Hodgkin lymphoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:190410

object_name: Embolism, Tumor


subject: CHEBI:190410

object_name: Neoplasm Metastasis


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: GTOPDB:11592

subject_name: evorpacept

object_name: Childhood Solid Neoplasm


subject: GTOPDB:11592

object_name: Adult Solid Neoplasm


subject: GTOPDB:11592

object_name: Solid Neoplasm


subject: GTOPDB:11592


subject: GTOPDB:11592


subject: GTOPDB:11592


subject: GTOPDB:11592


subject: GTOPDB:11592


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: prostate cancer, hereditary, 7


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Pain Disorder


subject: CHEBI:80555

subject_name: ENDOXIFEN

object_name: fibromatosis


subject: UMLS:C0957573


subject: UMLS:C3658854

object_name: Nasal Polyp


subject: UMLS:C4053581

object_name: metastatic melanoma


subject: UMLS:C4331002

subject_name: Personalized Peptide Cancer Vaccine NEO-PV-01


subject: CHEBI:90881

subject_name: Camptosar

object_name: rectal carcinoma


subject: CHEBI:90881

object_name: rectal cancer


subject: CHEBI:90881

object_name: Childhood Rectal Carcinoma


subject: CHEBI:90881

object_name: colon carcinoma


subject: CHEBI:90881

object_name: colon cancer


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: CHEBI:5847

subject_name: Raltitrexed


subject: CHEBI:5847


subject: CHEBI:5847


subject: CHEBI:5847


subject: CHEBI:5847


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C3539190

subject_name: Non-selective beta-adrenoreceptor agonists for systemic use

object_name: liver carcinoma


subject: UMLS:C3539190

object_name: Recurrent Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: HIV-1 infection


subject: CHEBI:32020

subject_name: Pitavastatin


subject: UMLS:C5543952

object_name: Acute Ischemic Stroke


subject: UMLS:C5543952

object_name: Ischemic stroke


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Advanced cancer


subject: UNII:6QVL057INT

object_name: trabecular adenocarcinoma


subject: UNII:6QVL057INT

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:6QVL057INT

object_name: carcinoma of esophagus


subject: UNII:6QVL057INT

object_name: esophageal cancer


subject: UNII:6QVL057INT

object_name: Childhood Esophageal Carcinoma


subject: UNII:6QVL057INT

object_name: neoplasm of esophagus


subject: UNII:6QVL057INT

object_name: pancreatic neoplasm


subject: UNII:6QVL057INT

object_name: exocrine pancreatic carcinoma


subject: UNII:6QVL057INT

object_name: malignant pancreatic neoplasm


subject: UNII:6QVL057INT

object_name: refractory malignant neoplasm


subject: UNII:6QVL057INT

object_name: ovarian cancer


subject: UNII:6QVL057INT

object_name: ovarian neoplasm


subject: UNII:6QVL057INT

object_name: ovarian carcinoma


subject: UNII:6QVL057INT

object_name: uterine cancer


subject: UNII:6QVL057INT

object_name: tumor of uterus


subject: UNII:6QVL057INT

object_name: bladder tumor


subject: UNII:6QVL057INT

object_name: urinary bladder carcinoma


subject: UNII:6QVL057INT

object_name: urinary bladder cancer


subject: UNII:6QVL057INT

object_name: childhood bladder carcinoma


subject: UNII:6QVL057INT

object_name: Stomach cancer


subject: UNII:6QVL057INT

object_name: gastric cancer


subject: UNII:6QVL057INT

object_name: thyroid tumor


subject: UNII:6QVL057INT

object_name: thyroid gland carcinoma


subject: UNII:6QVL057INT

object_name: thyroid cancer


subject: UNII:6QVL057INT

object_name: cervical cancer


subject: UNII:6QVL057INT

object_name: cervical carcinoma


subject: UNII:6QVL057INT

object_name: Childhood Breast Carcinoma


subject: UNII:6QVL057INT

object_name: breast carcinoma


subject: UNII:6QVL057INT

object_name: breast cancer


subject: UNII:6QVL057INT

object_name: renal carcinoma


subject: UNII:6QVL057INT

object_name: kidney neoplasm


subject: UNII:6QVL057INT

object_name: kidney cancer


subject: UNII:6QVL057INT

object_name: colon carcinoma


subject: UNII:6QVL057INT

object_name: colorectal cancer


subject: UNII:6QVL057INT

object_name: colon cancer


subject: UNII:6QVL057INT

object_name: malignant soft tissue neoplasm


subject: UNII:6QVL057INT

object_name: sarcoma


subject: UMLS:C4053601

object_name: Advanced cancer


subject: UMLS:C4053601

object_name: trabecular adenocarcinoma


subject: UMLS:C4053601

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C4053601

object_name: carcinoma of esophagus


subject: UMLS:C4053601

object_name: esophageal cancer


subject: UMLS:C4053601

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4053601

object_name: neoplasm of esophagus


subject: UMLS:C4053601

object_name: pancreatic neoplasm


subject: UMLS:C4053601

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4053601

object_name: malignant pancreatic neoplasm


subject: UMLS:C4053601

object_name: refractory malignant neoplasm


subject: UMLS:C4053601

object_name: ovarian cancer


subject: UMLS:C4053601

object_name: ovarian neoplasm


subject: UMLS:C4053601

object_name: ovarian carcinoma


subject: UMLS:C4053601

object_name: uterine cancer


subject: UMLS:C4053601

object_name: tumor of uterus


subject: UMLS:C4053601

object_name: bladder tumor


subject: UMLS:C4053601

object_name: urinary bladder carcinoma


subject: UMLS:C4053601

object_name: urinary bladder cancer


subject: UMLS:C4053601

object_name: childhood bladder carcinoma


subject: UMLS:C4053601

object_name: Stomach cancer


subject: UMLS:C4053601

object_name: gastric cancer


subject: UMLS:C4053601

object_name: thyroid tumor


subject: UMLS:C4053601

object_name: thyroid gland carcinoma


subject: UMLS:C4053601

object_name: thyroid cancer


subject: UMLS:C4053601

object_name: cervical cancer


subject: UMLS:C4053601

object_name: cervical carcinoma


subject: UMLS:C4053601

object_name: Childhood Breast Carcinoma


subject: UMLS:C4053601

object_name: breast carcinoma


subject: UMLS:C4053601

object_name: breast cancer


subject: UMLS:C4053601

object_name: renal carcinoma


subject: UMLS:C4053601

object_name: kidney neoplasm


subject: UMLS:C4053601

object_name: kidney cancer


subject: UMLS:C4053601

object_name: colon carcinoma


subject: UMLS:C4053601

object_name: colorectal cancer


subject: UMLS:C4053601

object_name: colon cancer


subject: UMLS:C4053601

object_name: malignant soft tissue neoplasm


subject: UMLS:C4053601

object_name: sarcoma


subject: UMLS:C5854596

subject_name: Anti-VISTA Monoclonal Antibody SNS-101

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854596

object_name: Adult Solid Neoplasm


subject: UMLS:C5854596

object_name: Advanced cancer


subject: UMLS:C5854596

object_name: Neck Carcinoma


subject: UMLS:C5854596

object_name: head and neck neoplasm


subject: UMLS:C5854596

object_name: head and neck cancer


subject: UMLS:C5854596

object_name: non-small cell lung carcinoma


subject: UMLS:C5854596

object_name: prostate carcinoma


subject: UMLS:C5854596

object_name: prostate cancer


subject: UMLS:C5854596

object_name: trabecular adenocarcinoma


subject: UMLS:C5854596

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5854596

object_name: carcinoma of esophagus


subject: UMLS:C5854596

object_name: esophageal cancer


subject: UMLS:C5854596

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5854596

object_name: neoplasm of esophagus


subject: UMLS:C5854596

object_name: pancreatic neoplasm


subject: UMLS:C5854596

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854596

object_name: malignant pancreatic neoplasm


subject: UMLS:C5854596

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5854596

object_name: Embolism, Tumor


subject: UMLS:C5854596

object_name: Neoplasm Metastasis


subject: UMLS:C5854596

object_name: refractory malignant neoplasm


subject: UMLS:C5854596

object_name: ovarian cancer


subject: UMLS:C5854596

object_name: ovarian neoplasm


subject: UMLS:C5854596

object_name: ovarian carcinoma


subject: UMLS:C5854596

object_name: uterine cancer


subject: UMLS:C5854596

object_name: tumor of uterus


subject: UMLS:C5854596

object_name: bladder tumor


subject: UMLS:C5854596

object_name: urinary bladder carcinoma


subject: UMLS:C5854596

object_name: urinary bladder cancer


subject: UMLS:C5854596

object_name: childhood bladder carcinoma


subject: UMLS:C5854596

object_name: Stomach cancer


subject: UMLS:C5854596

object_name: gastric cancer


subject: UMLS:C5854596

object_name: thyroid tumor


subject: UMLS:C5854596

object_name: thyroid gland carcinoma


subject: UMLS:C5854596

object_name: thyroid cancer


subject: UMLS:C5854596

object_name: cervical cancer


subject: UMLS:C5854596

object_name: cervical carcinoma


subject: UMLS:C5854596

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854596

object_name: breast carcinoma


subject: UMLS:C5854596

object_name: breast cancer


subject: UMLS:C5854596

object_name: renal carcinoma


subject: UMLS:C5854596

object_name: kidney neoplasm


subject: UMLS:C5854596

object_name: kidney cancer


subject: UMLS:C5854596

object_name: colon carcinoma


subject: UMLS:C5854596

object_name: colorectal cancer


subject: UMLS:C5854596

object_name: colon cancer


subject: UMLS:C5854596

object_name: melanoma


subject: UMLS:C5854596

object_name: malignant soft tissue neoplasm


subject: UMLS:C5854596

object_name: sarcoma


subject: UMLS:C1174836

object_name: neoplasm


subject: CHEBI:39112

subject_name: Bosutinib


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Childhood Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:131769963

object_name: recurrent childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:131769963

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:131769963

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:131769963

object_name: Blastic Phase


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent disease


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:31932

subject_name: olmesartan

object_name: Dyslipidemia


subject: UNII:9B29N23K7E

object_name: Childhood Breast Carcinoma


subject: UNII:9B29N23K7E

object_name: breast carcinoma


subject: UNII:9B29N23K7E

object_name: breast cancer


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Neoplasm, Residual


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: cytokine release syndrome


subject: UMLS:C5771998

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:168429725

subject_name: survodutide

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:168429725

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:2ALA66NS64

subject_name: SURVODUTIDE


subject: UNII:2ALA66NS64


subject: UMLS:C5773278


subject: UMLS:C5773278


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Cooley's anemia


subject: CHEBI:38290

object_name: beta thalassemia


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:31515

subject_name: Domperidone

object_name: Hypogalactia


subject: CHEBI:31515

object_name: postpartum history insufficient lactation


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: disorder of aging


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:73604

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:73604

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:73604

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Schnitzler syndrome


subject: UMLS:C2826229

object_name: Advanced cancer


subject: UMLS:C2826229

object_name: Stomach cancer


subject: UMLS:C2826229

object_name: gastric cancer


subject: UMLS:C2826229

object_name: colorectal cancer


subject: UMLS:C2826229

object_name: colorectal carcinoma


subject: UMLS:C2826229

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2826229

object_name: carcinoma of esophagus


subject: UMLS:C2826229

object_name: esophageal cancer


subject: UMLS:C2826229

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C2826229

object_name: neoplasm of esophagus


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: respiratory tract infectious disorder


subject: CHEBI:131327


subject: CHEBI:2674

subject_name: Amodiaquine


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Locally Advanced Gastric Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:31348

subject_name: Capecitabine


subject: UNII:3X8387Q25N

object_name: kidney failure


subject: UNII:QW2J7VST60

object_name: Kinetic tremor


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: knee pain chronic


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: osteoarthritis, knee


subject: CHEBI:144903


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C2349000

subject_name: Human Papillomavirus Vaccine V503

object_name: human papilloma virus infection


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: neuralgia


subject: PUBCHEM.COMPOUND:9834332

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:9834332

object_name: spinal cord injury


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Marijuana Use


subject: UMLS:C0678449

object_name: opioid use


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C0242402

subject_name: Opioids


subject: UMLS:C0242402


subject: DRUGBANK:DB18032

subject_name: Allogenic bone marrow-derived mesenchymal stem cells

object_name: hypoplastic left heart syndrome 1


subject: DRUGBANK:DB18032

object_name: hypoplastic left heart syndrome


subject: PUBCHEM.COMPOUND:25110515

subject_name: Ozanimod

object_name: Crohn disease


subject: UNII:HU43305R7O

object_name: age-related macular degeneration


subject: UNII:2C4Y86R2AX


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: endometrial carcinoma


subject: UNII:FBS8JQ0T3V

subject_name: Pterostilbene


subject: UNII:FBS8JQ0T3V

object_name: Endometrial Intraepithelial Neoplasia


subject: UNII:FBS8JQ0T3V

object_name: atypical endometrial hyperplasia


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: brain cancer


subject: UNII:YZS3R7LP44

object_name: brain neoplasm


subject: UMLS:C1310735

subject_name: Aloxi


subject: UMLS:C1310735


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Cannabis-Related Disorder


subject: CHEBI:8707

object_name: Cannabis-induced organic mental disorder


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:63631


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: septic shock


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: Congenital lactic acidosis


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: CHEBI:7824

subject_name: Oxcarbazepine


subject: CHEBI:7824

object_name: neuralgia


subject: CHEBI:7824

object_name: Neuralgia, CTCAE


subject: CHEBI:67271

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:67271

object_name: lung large cell carcinoma


subject: CHEBI:67271

object_name: squamous cell lung carcinoma


subject: CHEBI:67271

object_name: adenosquamous lung carcinoma


subject: CHEBI:67271

object_name: lung adenocarcinoma in situ


subject: CHEBI:67271

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:67271

object_name: lung adenocarcinoma


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:229652

subject_name: Iptacopan

object_name: lupus nephritis


subject: CHEBI:38940

subject_name: Sunitinib

object_name: esophageal adenocarcinoma


subject: CHEBI:38940


subject: CHEBI:38940

object_name: cervical adenocarcinoma


subject: CHEBI:38940

object_name: adenocarcinoma


subject: CHEBI:38940

object_name: bile duct adenocarcinoma


subject: CHEBI:38940

object_name: gastric adenocarcinoma


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Complex congenital heart disease


subject: CHEBI:6801

subject_name: Metformin

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:163322333

object_name: Childhood Synovial Sarcoma


subject: PUBCHEM.COMPOUND:163322333

object_name: Adult Synovial Sarcoma


subject: PUBCHEM.COMPOUND:163322333

object_name: synovial sarcoma


subject: PUBCHEM.COMPOUND:163322333

object_name: Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:163322333

object_name: Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:163322333

object_name: sarcoma


subject: PUBCHEM.COMPOUND:163322333

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:163322333

object_name: soft tissue sarcoma


subject: UMLS:C5706435


subject: UMLS:C5706435


subject: UMLS:C5706435


subject: UMLS:C5706435


subject: UMLS:C5706435


subject: UMLS:C5706435


subject: UMLS:C5706435


subject: UMLS:C5706435


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: biliary tract disorder


subject: CHEBI:17858

object_name: chronic liver failure


subject: CHEBI:17858

object_name: liver failure


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:16856

subject_name: Glutathione


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:73462

subject_name: Cys-Ser

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:73462

object_name: COPD, severe early onset


subject: CHEBI:73462

object_name: chronic obstructive pulmonary disease


subject: CHEBI:30514

subject_name: caesium atom


subject: CHEBI:30514


subject: CHEBI:30514


subject: UMLS:C1452745

object_name: Liver Fibrosis


subject: UMLS:C1452745

object_name: liver cirrhosis


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Lower Abdominal Pain


subject: CHEBI:51254

object_name: Acute appendicitis NOS (disorder)


subject: CHEBI:51254

object_name: Right iliac fossa pain


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:9927

subject_name: Valsartan

object_name: Blood Pressure Finding


subject: CHEBI:9927

object_name: Systemic arterial pressure


subject: CHEBI:9927

object_name: hypertension complicated


subject: CHEBI:4708

subject_name: Doxazosin

object_name: substance-related disorder


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Stomach cancer


subject: UNII:K16AIQ8CTM

object_name: gastric cancer


subject: UMLS:C0354100

subject_name: Loop Diuretics

object_name: ADHF


subject: UMLS:C3536704

subject_name: Loop Diuretic [EPC]


subject: CHEBI:231425

subject_name: tolvaptan


subject: UMLS:C3502472

object_name: kidney failure


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin


subject: PUBCHEM.COMPOUND:24984318

subject_name: Valbenazine


subject: DRUGBANK:DB05547

object_name: Alzheimer disease


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: immunoglobulin G4-related sclerosing disease


subject: UNII:73B0K5S26A

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:9241

subject_name: Spironolactone

object_name: hypertension


subject: CHEBI:9241

object_name: Hypertension, CTCAE


subject: UNII:69VKY8P7EA

object_name: Plexosarcoma


subject: UMLS:C2004126

subject_name: TKI 258


subject: UNII:4U7K5X4ANS

subject_name: Emeramide

object_name: Cooley's anemia


subject: PUBCHEM.COMPOUND:140987867

subject_name: Sulfonylurea

object_name: epilepsy


subject: PUBCHEM.COMPOUND:140987867

object_name: Developmental delay


subject: PUBCHEM.COMPOUND:140987867

object_name: neurodevelopmental disorder


subject: PUBCHEM.COMPOUND:140987867

object_name: intellectual disability


subject: PUBCHEM.COMPOUND:140987867

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:140987867

object_name: autism


subject: PUBCHEM.COMPOUND:140987867

object_name: autism spectrum disorder


subject: PUBCHEM.COMPOUND:140987867

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:140987867


subject: CHEBI:76983

subject_name: N-sulfonylurea


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:26831

subject_name: N,N''-sulfonyldiurea


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: MESH:D013453

subject_name: Sulfonylurea Compounds


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: UMLS:C3536898

subject_name: Sulfonylurea [EPC]


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: CHEBI:78543

subject_name: Ponatinib

object_name: thyroid tumor


subject: CHEBI:9907

subject_name: ursodiol

object_name: gallstones


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: liver carcinoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:71940

subject_name: Tadalafil

object_name: nephrolithiasis


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:10198924

subject_name: CHOLINE BITARTRATE

object_name: fetal alcohol spectrum disorder


subject: PUBCHEM.COMPOUND:10198924

object_name: fetal alcohol syndrome


subject: PUBCHEM.COMPOUND:10198924

object_name: Fetus or newborn affected by alcohol transmitted via placenta or breast milk


subject: GTOPDB:13768

subject_name: cagrilintide

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL4802169

subject_name: CAGRILINTIDE


subject: UMLS:C5198356

subject_name: PEGylated carboxyhemoglobin bovine

object_name: delayed function of renal transplant


subject: UMLS:C5198792

subject_name: Sanguinate


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Muscle Fatigue


subject: CHEBI:8228

object_name: Childhood Breast Carcinoma


subject: CHEBI:8228

object_name: breast carcinoma


subject: CHEBI:8228

object_name: breast cancer


subject: PUBCHEM.COMPOUND:3962

object_name: neurofibromatosis 1


subject: PUBCHEM.COMPOUND:3962

object_name: neurofibromatosis type 1


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Inflammatory Response


subject: UMLS:C1145201

object_name: end stage renal failure


subject: UMLS:C1145201

object_name: Chronic uremia


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:74067

subject_name: Ile-Ile

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:74067

object_name: pancreatic neoplasm


subject: CHEBI:74067

object_name: exocrine pancreatic carcinoma


subject: CHEBI:74067

object_name: malignant pancreatic neoplasm


subject: CHEBI:74067

object_name: lung cancer


subject: CHEBI:74067

object_name: lung neoplasm


subject: CHEBI:74067

object_name: lung carcinoma


subject: CHEBI:74067

object_name: vulva cancer


subject: CHEBI:74067

object_name: vulva carcinoma


subject: CHEBI:74067

object_name: cervical cancer


subject: CHEBI:74067

object_name: cervical carcinoma


subject: CHEBI:74067

object_name: Childhood Breast Carcinoma


subject: CHEBI:74067

object_name: breast carcinoma


subject: CHEBI:74067

object_name: breast cancer


subject: CHEBI:74067

object_name: ovarian cancer


subject: CHEBI:74067

object_name: ovarian neoplasm


subject: CHEBI:74067

object_name: ovarian carcinoma


subject: CHEBI:74067

object_name: thyroid tumor


subject: CHEBI:74067

object_name: thyroid gland carcinoma


subject: CHEBI:74067

object_name: thyroid cancer


subject: CHEBI:74067

object_name: colorectal cancer


subject: CHEBI:74067

object_name: colorectal carcinoma


subject: CHEBI:74067

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain

object_name: Advanced Malignant Solid Neoplasm


subject: PR:000001822

object_name: pancreatic neoplasm


subject: PR:000001822

object_name: exocrine pancreatic carcinoma


subject: PR:000001822

object_name: malignant pancreatic neoplasm


subject: PR:000001822

object_name: lung cancer


subject: PR:000001822

object_name: lung neoplasm


subject: PR:000001822

object_name: lung carcinoma


subject: PR:000001822

object_name: vulva cancer


subject: PR:000001822

object_name: vulva carcinoma


subject: PR:000001822

object_name: cervical cancer


subject: PR:000001822

object_name: cervical carcinoma


subject: PR:000001822

object_name: Childhood Breast Carcinoma


subject: PR:000001822

object_name: breast carcinoma


subject: PR:000001822

object_name: breast cancer


subject: PR:000001822

object_name: ovarian cancer


subject: PR:000001822

object_name: ovarian neoplasm


subject: PR:000001822

object_name: ovarian carcinoma


subject: PR:000001822

object_name: thyroid tumor


subject: PR:000001822

object_name: thyroid gland carcinoma


subject: PR:000001822

object_name: thyroid cancer


subject: PR:000001822

object_name: colorectal cancer


subject: PR:000001822

object_name: colorectal carcinoma


subject: PR:000001822

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000007904

object_name: Advanced Malignant Solid Neoplasm


subject: PR:000007904

object_name: pancreatic neoplasm


subject: PR:000007904

object_name: exocrine pancreatic carcinoma


subject: PR:000007904

object_name: malignant pancreatic neoplasm


subject: PR:000007904

object_name: lung cancer


subject: PR:000007904

object_name: lung neoplasm


subject: PR:000007904

object_name: lung carcinoma


subject: PR:000007904

object_name: vulva cancer


subject: PR:000007904

object_name: vulva carcinoma


subject: PR:000007904

object_name: cervical cancer


subject: PR:000007904

object_name: cervical carcinoma


subject: PR:000007904

object_name: Childhood Breast Carcinoma


subject: PR:000007904

object_name: breast carcinoma


subject: PR:000007904

object_name: breast cancer


subject: PR:000007904

object_name: ovarian cancer


subject: PR:000007904

object_name: ovarian neoplasm


subject: PR:000007904

object_name: ovarian carcinoma


subject: PR:000007904

object_name: thyroid tumor


subject: PR:000007904

object_name: thyroid gland carcinoma


subject: PR:000007904

object_name: thyroid cancer


subject: PR:000007904

object_name: colorectal cancer


subject: PR:000007904

object_name: colorectal carcinoma


subject: PR:000007904

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3899498

subject_name: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A

object_name: Locally Advanced Rectal Carcinoma


subject: UMLS:C3899498

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C3899498

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UMLS:C3899498

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UMLS:C3899498

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Decompensated cardiac failure


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: acute liver failure


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Heart Failure, CTCAE


subject: CHEBI:90865

subject_name: Flibanserin

object_name: prostate adenocarcinoma


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: herpes zoster


subject: UMLS:C5398044

object_name: Vaccine adverse reaction


subject: UMLS:C5398044

object_name: viral disease


subject: UMLS:C5398044

object_name: RNA Virus Infections


subject: UMLS:C5398044

object_name: respiratory tract infectious disorder


subject: UMLS:C5417955


subject: UMLS:C5417955


subject: UMLS:C5417955


subject: UMLS:C5417955


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: UMLS:C5417956


subject: UMLS:C5417956


subject: UMLS:C5417956


subject: UMLS:C5417956


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine

object_name: Morbidity


subject: UMLS:C0032375

object_name: mortality


subject: UMLS:C0032375

object_name: Growth & development aspects


subject: CHEBI:41001

subject_name: Benzoylecgonine


subject: CHEBI:41001


subject: CHEBI:41001


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: PUBCHEM.COMPOUND:251912


subject: PUBCHEM.COMPOUND:251912


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C2698319


subject: UMLS:C2698319


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PR:000002994


subject: PR:000002994


subject: CHEBI:75551

object_name: relapsing-remitting multiple sclerosis


subject: UNII:9J7J08A8LT

subject_name: REMIMAZOLAM TOSYLATE

object_name: Sedation complication


subject: UNII:9J7J08A8LT

object_name: Hypoxemia


subject: UNII:9J7J08A8LT

object_name: Hypoxia, CTCAE


subject: UNII:9J7J08A8LT

object_name: Propofol adverse reaction


subject: UNII:9J7J08A8LT

object_name: Stomach cancer


subject: UNII:9J7J08A8LT

object_name: gastric cancer


subject: CHEBI:27849

subject_name: p-Toluenesulfonic acid


subject: CHEBI:27849


subject: CHEBI:27849


subject: CHEBI:27849


subject: CHEBI:27849


subject: CHEBI:27849


subject: PUBCHEM.COMPOUND:62690

subject_name: carbogen

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297716

subject_name: CARBOGEN


subject: CHEBI:28240

subject_name: dichloroacetate


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: UMLS:C1521807


subject: UMLS:C4055105

subject_name: EGFR Antibody

object_name: Stage IV Nasopharyngeal Carcinoma


subject: UMLS:C4055105

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Myelodysplasia


subject: CHEBI:233364

object_name: leukemia


subject: CHEBI:233364

object_name: childhood leukemia


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: B-cell lymphoma refractory


subject: UMLS:C4725069

subject_name: glofitamab


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:7K5O7P6QIU

object_name: B-cell neoplasm


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab


subject: UMLS:C4329313


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UNII:KG6VO684Z6


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UNII:41J7ZJ239R

object_name: neoplasm of esophagus


subject: UNII:41J7ZJ239R

object_name: gastric neoplasm


subject: UMLS:C5667086

subject_name: Nectin-4-directed TLR8 Agonist SBT6290

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5667086

object_name: triple-negative breast carcinoma


subject: UMLS:C5667086

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5667086

object_name: non-small cell lung carcinoma


subject: UMLS:C5667086

object_name: urothelial carcinoma


subject: UMLS:C5667086

object_name: transitional cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5314525

subject_name: LERAMISTAT

object_name: interstitial lung disease 1


subject: CHEMBL.COMPOUND:CHEMBL5314525

object_name: interstitial lung disease 2


subject: UNII:38E2HYD3AW


subject: UNII:38E2HYD3AW


subject: UMLS:C5909107

subject_name: Leramistat


subject: UMLS:C5909107


subject: CHEBI:32599

object_name: pain agnosia


subject: CHEBI:32599

object_name: Pain insensitivity


subject: CHEBI:31355

subject_name: Carboplatin

object_name: uterine cancer


subject: CHEBI:31355

object_name: tumor of uterus


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:83766

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:83766

object_name: Ovarian cancer stage IV


subject: CHEBI:83766

object_name: Ovarian cancer stage III


subject: CHEBI:83766

object_name: Stage III Ovarian Cancer AJCC v8


subject: DRUGBANK:DB17601

subject_name: Ixmyelocel-T

object_name: cleft palate


subject: DRUGBANK:DB17601

object_name: isolated cleft palate


subject: DRUGBANK:DB17601

object_name: cleft palate on exam


subject: DRUGBANK:DB17601

object_name: Physical trauma


subject: DRUGBANK:DB17601

object_name: Injury


subject: DRUGBANK:DB17601

object_name: Trauma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: amyloidosis


subject: CHEBI:73604

object_name: AL amyloidosis


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Rotator cuff impingement syndrome


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID

object_name: shoulder impingement syndrome